Nepal’s God of Sight eye doctor to expand work beyond border
Nepal’s “God of Sight” eye doctor renowned for his innovative and inexpensive cataract surgery for the poor is taking his work beyond the Himalayan mountains so there is no more unnecessary blindness in the world (Source: ABC News: Health)
Source: ABC News: Health - April 8, 2021 Category: Consumer Health News Tags: Health Source Type: news

LSU Health New Orleans study discovers source of Zika neurodevelopmental defects
(Louisiana State University Health Sciences Center) A study led by Edward Wojcik, PhD, Associate Professor of Biochemistry& Molecular Biology at LSU Health New Orleans School of Medicine, identified how microcephaly (abnormally small heads) and blindness may develop in Zika-infected fetuses, as well as a new way to potentially prevent these neurodevelopmental defects. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 6, 2021 Category: Infectious Diseases Source Type: news

New perspective to understand and treat a rare calcification disease
(E ö tv ö s Lor á nd University (ELTE), Faculty of Science) As part of an international collaboration, researchers from ELTE E ö tv ö s Lor á nd University developed a new animal model to study a rare genetic disease that can lead to blindness at the age of 40-50. The new model could open up new perspectives in our understanding of this metabolic disease and will also help to identify new potential drug candidates. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2021 Category: International Medicine & Public Health Source Type: news

Marijuana for glaucoma treatment: a recipe for disaster - Daga FB, Almeida I, Prata TS, Paranhos AJ.
Glaucoma is the leading cause of irreversible blindness worldwide(1). It occurs more frequently in elderly individuals, but it can also develop in young adults, children, and newborns. Glaucoma is characterized by the dysfunction and loss of retinal gangli... (Source: SafetyLit)
Source: SafetyLit - April 4, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Diabetes type 2: Glaucoma result of high blood sugar levels and may lead to blindness
DIABETES type 2 has the ability to affect almost every body part, hence the need for a person to safely manage this condition by monitoring their blood sugar levels and eating correctly. Failing to do this could result in blindness, warn healthcare professionals. (Source: Daily Express - Health)
Source: Daily Express - Health - March 30, 2021 Category: Consumer Health News Source Type: news

An efficacy and safety study of intra-arterial recanalization of occluded ophthalmic arteries in patients with monocular blindness caused by injection of hyaluronic acid in facial tissues - Wang J, Shen H, Liu T, Li Q, Lyu Z, Yu Y.
PROPOSE: To evaluate the efficacy and safety of recanalizing hyaluronic acid-occluded retinal central artery by intra-arterially infusing hyaluronidase. METHODS: Between December 2015 and December 2016, 30 patients with monocular blindness due to t... (Source: SafetyLit)
Source: SafetyLit - March 30, 2021 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Gold dust in your contact lenses could help colour blindness, research shows 
These 'gold dust' particles filter out certain wavelengths of light, so the brain can distinguish between different colours, particularly reds and greens, more easily. (Source: the Mail online | Health)
Source: the Mail online | Health - March 30, 2021 Category: Consumer Health News Source Type: news

Sobrin Receives Research to Prevent Blindness Physician-Scientist Award
Lucia Sobrin, MD, MPH, of the Division of Ophthalmology, won the Physician-Scientist Award from Research to Prevent Blindness (RPB) for her work in identifying genes that influence the risk of developing ocular hypertension after corticosteroid use. (Source: BWH News)
Source: BWH News - March 29, 2021 Category: Hospital Management Source Type: news

CorneaGen CEO transitions to advisory role, new president named
Seattle-based CorneaGen CEO Monty Montoya transitioned to a strategic advisory role, the company confirmed Wednesday. CorneaGen promoted Bernardino “Bernie” Iliakis from chief operating officer to president to lead the biotech, which works to eliminate corneal blindness. Montoya, who founded the company in 2016, has served as its president and CEO until the transition this year. Prior to founding CorneaGen, Montoya was president and CEO of SightLife, a Seattle-based nonprofit and provider of… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 24, 2021 Category: American Health Authors: Megan Campbell Source Type: news

AHA News: Stroke, Blindness, a Heart Transplant – And a Can-Do Spirit
Title: AHA News: Stroke, Blindness, a Heart Transplant – And a Can-Do SpiritCategory: Health NewsCreated: 3/23/2021 12:00:00 AMLast Editorial Review: 3/24/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 24, 2021 Category: Cardiology Source Type: news

AHA News: Stroke, Blindness, a Heart Transplant – And a Can-Do Spirit
TUESDAY, March 23, 2021 (American Heart Association News) -- Hana Hooper went to college with dreams of becoming a veterinarian. She aspired to boost her knowledge of biology and intended to amplify her interest in art. She was 18, and her future... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 23, 2021 Category: General Medicine Source Type: news

Psychometric properties of the suicide Stroop task in a Chinese college population - Niu L, Feng X, Jia Z, Yu Y, Zhou L.
This study aimed to test the psychometric properties of the suicide stroop task in a Chinese college population. METHODS: College students (n = 121) who were in the 1st-4th grade, fluent in Chinese, and without color blindness were recru... (Source: SafetyLit)
Source: SafetyLit - March 20, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Upstate vision researcher lands $2.6 million NIH grant and prestigious national innovation award
Professor Peter Calvert, PhD, studies diseases that cause blindness. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - March 12, 2021 Category: Universities & Medical Training Tags: News Research Source Type: news

I ain't afraid of no ghosts: people with mind-blindness not so easily spooked
(University of New South Wales) The link between mental imagery and emotions may be closer than we thought. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 10, 2021 Category: International Medicine & Public Health Source Type: news

Gene therapy trial for age-related macular degeneration now open at Columbia
(Columbia University Irving Medical Center) A clinical trial to test a gene therapy for some patients with dry age-related macular degeneration -- a leading cause of blindness in the United States -- is underway at Columbia and NewYork-Presbyterian. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 9, 2021 Category: International Medicine & Public Health Source Type: news

Study shows that mortality is associated with vision impairment
Researchers recently during a meta-analysis found that blindness and impairment of vision are closely associated with increased mortality risk. (Source: The Economic Times)
Source: The Economic Times - March 7, 2021 Category: Consumer Health News Source Type: news

Vision impairment is associated with mortality
(Michigan Medicine - University of Michigan) A meta-analysis finds that vision impairment and blindness are tied to an increased risk of mortality, prompting the need to address global eye health disparities. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 5, 2021 Category: International Medicine & Public Health Source Type: news

Scientists Gain Insight Into Genetics of Glaucoma
WEDNESDAY, March 3, 2021 -- Researchers have identified 44 new genetic variants associated with glaucoma, a leading cause of blindness. They say their findings could provide new targets to treat the common eye disease. In their study, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 3, 2021 Category: General Medicine Source Type: news

Color blindness-correcting contact lenses
(American Chemical Society) Imagine seeing the world in muted shades -- gray sky, gray grass. Some people with color blindness see everything this way, though most can't see specific colors. Tinted glasses can help, but they can't be used to correct blurry vision. And dyed contact lenses currently in development for the condition are potentially harmful and unstable. Now, inACS Nano, researchers report infusing contact lenses with gold nanoparticles to create a safer way to see colors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 3, 2021 Category: International Medicine & Public Health Source Type: news

A new blindness gene uncovered in a canine study
(University of Helsinki) A study recently completed at the University of Helsinki has uncovered a mutation in the IFT122 gene in blind dogs. The gene defect now discovered results in the progressive destruction of photoreceptor cells and retinal dystrophy. IFT122 is a new candidate also for retinal dystrophy in humans. A gene test in support of breeding and diagnostics has been developed based on the finding. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 2, 2021 Category: International Medicine & Public Health Source Type: news

Ethiopia: Exemplary Deed That Everyone Has to Second
[Ethiopian Herald] There is nothing as saddening as seeing people suffering from an avoidable or easily treatable vision problems. As documents indicate, globally, particularly in developing countries, a large number of people of all ages face vision problems and long term blindness due to ailments that can be treated or prevented easily. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 23, 2021 Category: African Health Source Type: news

After the Nobel, what next for Crispr  gene-editing therapies?
Hailed as the ‘molecular scissors’ that will allow us to rewrite our genes, the DNA tool is being trialled in treatments for everything from sickle-cell anaemia to cancerWhen last year ’s Nobel prize for chemistry was awarded tobiochemist Jennifer Doudna and microbiologist Emmanuelle Charpentier for their work in developing the technique of gene editing known as Crispr-Cas9 (pronounced “crisper”), headlines hailed their discovery as “molecular scissors” that would allow us to “rewrite the book of life” – with all the complicated ethical questions that ability rais...
Source: Guardian Unlimited Science - February 21, 2021 Category: Science Authors: Philip Ball Tags: Gene editing Medical research Genetics Biology Science Cancer Huntington's disease Sickle cell disease Source Type: news

Researchers explore 'face blindness' in children
(University of Stirling) Researchers have launched a new study into a little-known phenomenon which prevents people from recognizing members of their own immediate family or sometimes even their own reflection. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 19, 2021 Category: International Medicine & Public Health Source Type: news

Bringing innovation to rare disease patients in Europe
Why is Biogen focusing on rare diseases?  About 6,000 different rare diseases have been identified to date and these are estimated to affect 30 million people across Europe. It is essential that we collaborate across the medical community, industry, and governments to develop new therapies, explore new technologies and ensure equitable access to treatment. We must innovate across every aspect of treatment to transform the lives of people in these underserved communities.  At Biogen, we have shown that pioneering in neuroscience can change the course of treatment for certain rare diseases. We have transformed the ...
Source: EyeForPharma - February 17, 2021 Category: Pharmaceuticals Authors: Izzy Gladstone Source Type: news

COVID casualty: bilateral blindness due to ingestion of spurious sanitizer - Kochgaway L, Nair AG, Mitra A, Bhargava S, Singh M.
Intentional ingestion of alcohol-based handrub (ABHR) or sanitizer solution is uncommon. The coronavirus disease-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 has led to lockdowns being put in place in many countries across the glob... (Source: SafetyLit)
Source: SafetyLit - February 8, 2021 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Clinical trials begin to investigate treatment for diabetic eye disease
A new approach to treating one of the leading causes of blindness among patients with diabetes is being tested in clinical trials which begin this month. (Source: University of Bristol news)
Source: University of Bristol news - February 8, 2021 Category: Universities & Medical Training Tags: Health, Research, Business and Enterprise; Faculty of Life Sciences, School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences; Press Release Source Type: news

New research sheds light on vision loss in Batten disease
(University of Rochester Medical Center) Progressive vision loss, and eventually blindness, are the hallmarks of juvenile neuronal ceroid lipofuscinosis (JNCL) or CLN3-Batten disease. New research shows how the mutation associated with the disease could potentially lead to degeneration of light sensing photoreceptor cells in the retina, and subsequent vision loss. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 5, 2021 Category: International Medicine & Public Health Source Type: news

Sustained Blindness Risk Higher With Severe Diabetic Retinopathy at Diagnosis
WEDNESDAY, Feb. 3, 2021 -- More advanced diabetic retinopathy (DR) at first diagnosis is a significant risk factor for developing sustained blindness over two years, according to a study published online Jan. 20 in Diabetes Care. Charles C. Wykoff,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 3, 2021 Category: Pharmaceuticals Source Type: news

Halved risk for severe retinal disease in extremely premature infants
(University of Gothenburg) Risk for a severe form of retinopathy of prematurity, which can cause blindness in extremely premature babies, was halved when the newborns were given a new supplement combining various fatty acids. This was shown in a Swedish study led from the University of Gothenburg. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2021 Category: International Medicine & Public Health Source Type: news

Nigeria: In the Midst of a Pandemic, Nigeria Battles to End a Painful Blinding Disease
[Thomson Reuters Foundation] Health experts warn COVID-19 could hamper efforts to tackle trachoma, the leading infectious cause of blindness in the world (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 29, 2021 Category: African Health Source Type: news

Ocular injury in pediatric patients admitted with major trauma - Truong T, Sobol EK, Parsikia A, Mbekeani JN.
An estimated 2.4 million eye injuries occur in the United States, 35% of which occur in children under the age of 17years. Ocular trauma is a leading cause of childhood visual impairment and blindness and concurrence with other trauma can result in complic... (Source: SafetyLit)
Source: SafetyLit - January 27, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

New techniques help decrease the risk of developing age-related eye disease
With life expectancy on the rise, more and more people are at risk of developing age-related eye diseases that could cause blindness. The key to treating and managing such diseases is to understand the risk factors involved. To help, one EU-funded project has developed tools that predict not only how likely a person is to develop eye diseases but also what can be done to lower this risk. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - January 26, 2021 Category: Research Source Type: news

Roche ’s faricimab meets primary endpoint in two global phase III studies and shows potential to extend time between treatments up to 16 weeks for people with neovascular age-related macular degeneration
Basel, 25 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global phase III studies, TENAYA and LUCERNE, evaluating its investigational bispecific antibody, faricimab, in people living with neovascular or “wet” age-related macular degeneration (nAMD). Both studies met their primary endpoint and showed that people receiving faricimab injections at fixed intervals of up to every 16 weeks achieved visual acuity outcomes that were non-inferior to those receiving aflibercept injections every eight wee ks. Nearly half (45%) of people in both stud...
Source: Roche Investor Update - January 25, 2021 Category: Pharmaceuticals Source Type: news

Roche ’s faricimab meets primary endpoint in two global phase III studies and shows potential to extend time between treatments up to 16 weeks for people with neovascular age-related macular degeneration
Basel, 25 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global phase III studies, TENAYA and LUCERNE, evaluating its investigational bispecific antibody, faricimab, in people living with neovascular or “wet” age-related macular degeneration (nAMD). Both studies met their primary endpoint and showed that people receiving faricimab injections at fixed intervals of up to every 16 weeks achieved visual acuity outcomes that were non-inferior to those receiving aflibercept injections every eight wee ks. Nearly half (45%) of people in both stud...
Source: Roche Media News - January 25, 2021 Category: Pharmaceuticals Source Type: news

Genome editing to treat human retinal degeneration
(Mary Ann Liebert, Inc./Genetic Engineering News) Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness. Technological advances in gene editing, continuing safety concerns, and strategies to overcome these challenges (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 25, 2021 Category: International Medicine & Public Health Source Type: news

Promising Steps Toward Retinal Cell Transplants to Fight Blindness
Title: Promising Steps Toward Retinal Cell Transplants to Fight BlindnessCategory: Health NewsCreated: 1/19/2021 12:00:00 AMLast Editorial Review: 1/20/2021 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - January 20, 2021 Category: Opthalmology Source Type: news

Promising Steps Toward Retinal Cell Transplants to Fight Blindness
TUESDAY, Jan. 19, 2021 -- A promising step toward using retinal cell transplants to treat blindness is reported in a new study. Adult retinal stem cells from deceased human donors survived when they were transplanted into the eyes of non-human... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 19, 2021 Category: General Medicine Source Type: news

Genome editing to treat human retinal degeneration
(Mary Ann Liebert, Inc./Genetic Engineering News) Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness. Technological advances in gene editing, continuing safety concerns, and strategies to overcome these challenges (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 19, 2021 Category: International Medicine & Public Health Source Type: news

Retinal stem cells from cadavers may help restore vision in blind, study finds
Retinal stem cells collected from human cadavers offer a potential treatment for blindness, according to the authors of an article published Thursday by Stem Cell Reports. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 14, 2021 Category: Consumer Health News Source Type: news

55 scientists funded to explore their research's commercial potential
(European Research Council) A new low-cost test for COVID19, how to share cultural expertise to solve conflicts, a way to help develop new medicines to treat blindness, further improvements to a clean energy producing technology - just some examples of how frontier researchers will use extra ERC funding to improve our lives. 55 researchers will receive ERC Proof of Concept grants to explore the commercial or societal potential of their work and to bring their work closer to the market. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 7, 2021 Category: International Medicine & Public Health Source Type: news

The United States Eye Injury Registry: past and future directions - Chen A, McGwin GJ, Justin GA, Woreta FA.
Worldwide, eye trauma is a significant burden and the leading cause of monocular blindness. An estimated 3.15 per 1000 population eye injuries are treated every year in emergency departments throughout the United States. Additionally, nearly one third of p... (Source: SafetyLit)
Source: SafetyLit - January 5, 2021 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

How Good is Photoscreening For Young Children ’ s Vision Problems?
This study showed that not only was smartphone photoscreening feasible, but was quite good at screening for potential vision problems. Smartphone photoscreening has the advantages of being more ubiquitously available and thus children in almost any location can be screened. A study of photoscreening using a handheld digital photoscreener in primary care offices validated the technology showing an overall referral rate of 10% to an ophthalmologist with suspected astigmatism, anisometropia and strabismus being the most common reasons. The overall positive predictive rate was 0.60. “…[O]ver 60% of children referr...
Source: PediatricEducation.org - January 4, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Thousands at risk of blindness set to benefit from a new eye drug
Brolucizumab, has now been approved by NHS chiefs for patients with wet age-related macular deterioration - a painless yet incurable eye disease that's the leading cause of blindness in over-55s. (Source: the Mail online | Health)
Source: the Mail online | Health - January 2, 2021 Category: Consumer Health News Source Type: news

Why Do We Dream? A New Theory on How It Protects Our Brains
When he was two years old, Ben stopped seeing out of his left eye. His mother took him to the doctor and soon discovered he had retinal cancer in both eyes. After chemotherapy and radiation failed, surgeons removed both his eyes. For Ben, vision was gone forever. But by the time he was seven years old, he had devised a technique for decoding the world around him: he clicked with his mouth and listened for the returning echoes. This method enabled Ben to determine the locations of open doorways, people, parked cars, garbage cans, and so on. He was echolocating: bouncing his sound waves off objects in the environment and cat...
Source: TIME: Science - December 29, 2020 Category: Science Authors: David Eagleman and Don Vaughn Tags: Uncategorized Source Type: news

'Liquid nose jobs' outlawed for B.C. naturopaths over concerns about blindness and skin death
Naturopaths in B.C. have been banned from performing liquid rhinoplasty, a procedure marketed as a quick and relatively painless alternative to surgery that nonetheless can cause serious complications. (Source: CBC | Health)
Source: CBC | Health - December 24, 2020 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

Reflecting Back and Imagining Forward
By Anis ChowdhurySYDNEY, Dec 24 2020 (IPS) What a challenging year 2020 has been! A year of living dangerously – “Tahun vivere pericoloso”- perhaps these words of late President Soekarno of Indonesia are the best description. Fortunately, I managed to remain sane, reading and writing op-eds (mostly about the pandemic, here, here). Anis ChowdhuryI began the year 2020 with an interview with New Age (Dhaka, 12 Feb.), headlined, “We need to Democratise Politics” where I highlighted the perils of growing inequality and how it could be a greater threat than the evolving pandemic for the human race...
Source: IPS Inter Press Service - Health - December 24, 2020 Category: International Medicine & Public Health Authors: Anis Chowdhury Tags: Climate Change Economy & Trade Environment Financial Crisis Global Headlines Health Humanitarian Emergencies Inequity Labour TerraViva United Nations Source Type: news

Roche ’s faricimab meets primary endpoint and shows strong durability across two global phase III studies for diabetic macular edema, a leading cause of blindness
Basel, 21 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global phase III studies, YOSEMITE and RHINE, evaluating its investigational bispecific antibody, faricimab, in people living with diabetic macular edema (DME). Both studies met their primary endpoint and showed that faricimab given every eight weeks and at personalised dosing intervals of up to 16 weeks demonstrated non-inferior visual acuity gains compared to aflibercept given every eight weeks. Faricimab was generally well-tolerated, with no new safety signals identified. The studies each h...
Source: Roche Media News - December 21, 2020 Category: Pharmaceuticals Source Type: news

Roche ’s faricimab meets primary endpoint and shows strong durability across two global phase III studies for diabetic macular edema, a leading cause of blindness
Basel, 21 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global phase III studies, YOSEMITE and RHINE, evaluating its investigational bispecific antibody, faricimab, in people living with diabetic macular edema (DME). Both studies met their primary endpoint and showed that faricimab given every eight weeks and at personalised dosing intervals of up to 16 weeks demonstrated non-inferior visual acuity gains compared to aflibercept given every eight weeks. Faricimab was generally well-tolerated, with no new safety signals identified. The studies each h...
Source: Roche Investor Update - December 21, 2020 Category: Pharmaceuticals Source Type: news

Thousands are risking blindness because they don't use their eye drops properly, warn experts
The concern follows recent reports that only half of the 480,000 sufferers of glaucoma - the most common eye condition in the UK - are given clear instructions for using their medication. (Source: the Mail online | Health)
Source: the Mail online | Health - December 19, 2020 Category: Consumer Health News Source Type: news

Penn vision researchers honored by End Blindness 2020
(University of Pennsylvania) The Outstanding Achievement Prize highlights the contributions of the School of Veterinary Medicine's Gustavo D. Aguirre and the Perelman School of Medicine's Jean Bennett and Albert M. Maguire toward a gene therapy for a form of blindness. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 15, 2020 Category: International Medicine & Public Health Source Type: news